XML 20 R4.htm IDEA: XBRL DOCUMENT v3.24.2.u1
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
 3 Months Ended 6 Months Ended
Jun. 30, 2024
Jun. 30, 2023
Jun. 30, 2024
Jun. 30, 2023
Grant revenue $ 3,288,971 $ 1,719,944 $ 5,636,221 $ 3,127,812
Operating expenses:        
Research and development 3,772,391 1,958,388 6,586,649 3,791,662
General and administrative 2,511,679 992,553 4,639,609 1,993,466
Total operating expenses 6,284,070 2,950,941 11,226,258 5,785,128
Loss from operations (2,995,099) (1,230,997) (5,590,037) (2,657,316)
Other income (expense):        
Other income (expense) (247) (212,211) (277) 644,368
Interest income 678,441 17,707 759,074 53,111
Total other income, net 678,194 (194,504) 758,797 697,479
Net loss $ (2,316,905) $ (1,425,501) $ (4,831,240) $ (1,959,837)
Per share information:        
Net loss per share of common stock, basic and diluted (in dollars per share) $ (0.27) $ (2.75) $ (0.65) $ (3.78)
Weighted average shares outstanding, basic and diluted (in shares) 8,702,764 518,140 7,436,633 518,140
Comprehensive loss:        
Net unrealized loss on marketable securities $ (19,702) $ 0 $ (19,702) $ 0
Total comprehensive loss $ (2,336,607) $ (1,425,501) $ (4,850,942) $ (1,959,837)